Sale of AC8 and CPH, purchase of BOT and BRN

Wednesday 5 April This morning I sold out of two cannabis biotechs and bought into another, plus got back into an old favourite. Auscann Group Holdings (AC8, 79.5¢, $84m) was sold at 79.5¢ after it broke support. I had bought them at 69¢ a week or two ago so made a small profit. Creso Pharma (CPH, … Read more

To access this post, you must purchase a membership.